Month 2018
Design, Synthesis, Safener Activity of Novel N-Substituted Thiazide/Thiazole
Derivatives
2,2-Dimethyl-N-[(p-methylphenyl)sulfonyl]-thiazolidine-3-
formamide (3a).
2.45 (s, 3H). 13C-NMR (75 MHz, CDCl3, ppm): δ: 149.38,
144.93, 135.93, 135.09, 130.18, 129.62, 128.53, 128.53,
128.39, 128.39, 127.48, 124.99, 41.55, 28.33, 21.77. HRMS
(ESI): m/z calcd for C24H24N2NaO3S2 ([M + Na]+) 371.0602
found 371.0494.
White solid. Yield 76%. m.p. 147–
149°C. IR (KBr, cmꢀ1) ν: 3310 (N-H), 2970 (C-H), 1701
(C=O), 1347, 1164 (O=S=O). 1H-NMR (600 MHz,
DMSO-d6, ppm): δ: 7.79–7.38 (m, 4H), 7.26 (s, 1H), 3.82
(t, J = 6.0 Hz, 1H), 3.23 (t, J = 6.0 Hz, 1H), 3.00 (t,
J = 6.0 Hz, 1H), 2.95 (t, J = 6.0 Hz, 1H), 2.38 (d,
J = 8.4 Hz, 1H), 1.59 (s, 3H), 1.49(s, 3H). 13C-NMR
(150 MHz, DMSO-d6, ppm): δ: 141.82, 141.42, 129.27,
129.27, 127.32, 125.59, 125.59, 52.60, 31.09, 28.30,
28.27, 27.04, 20.89. HRMS (ESI): m/z calcd for
General procedure for the preparation of acylation
benzothiazine derivatives 3f–h.
The intermediate 2e
(4 mmol), anhydrous Na2CO3 (3 mmol), and 10-mL
benzene were mixed. Acyl chloride (4.8 mmol) was added
dropwise at room temperature. The mixture was stirred for
1–2 h, washed with saturated NaCl, and then dried over
anhydrous MgSO4. Benzene was evaporated under vacuum.
C13H18N2O3S2 ([M + H]+) 315.0759 found 315.0836.
2-Ethyl-2-methyl-N-[(p-methylphenyl)sulfonyl]-thiazolidine-
The pure products were obtained by recrystallization.
N-Dichloroacetyl-3,4-dihydro-2H-1,4-benzothiazine (3f).
3-formamide (3b).
White solid. Yield 74%. m.p. 167–
169°C. IR (KBr, cmꢀ1) ν: 3321 (N-H), 2934 (C-H), 1696
(C=O), 1368, 1163(O=S=O). 1H-NMR (600 MHz,
CDCl3, ppm): δ: 7.94–7.33 (m, J = 8.4 Hz, 4H), 3.84–
3.80 (m, 1H), 3.75–3.71 (m, 1H), 2.96–2.86 (m, 2H),
2.45 (s, 3H), 2.19–2.05 (m, 1H), 1.85–1.91 (m, 1H), 1.68
(s, 3H), 0.79 (s, 3H). 13C-NMR (150 MHz, CDCl3,
ppm): δ: 148.04, 144.48, 136.43, 129.54, 129.54, 128.08,
128.08, 77.18, 52.87, 32.19, 27.66, 27.48, 21.66, 9.56.
HRMS (ESI): m/z calcd for C14H20N2O3S2 ([M + H]+)
Yellow solid. Yield 33%. m.p. 139–141°C. IR (KBr,
cmꢀ1) ν: 3019 (C-H), 1685 (C=O), 1475–1315 (C=C). 1H-
NMR (300 MHz, CDCl3, ppm): δ: 7.33–7.15 (m, 4H),
6.40(s, 1H), 4.14–3.27 (m, 4H). 13C-NMR (75 MHz,
CDCl3, ppm): δ: 163.66, 136.12, 130.83, 128.29, 128.06,
125.41, 124.84, 63.59, 42.95, 28.01. MS (ESI): m/z calcd
for C10H9Cl2NOS ([M + H]+) 261.9855 found 261.9852.
Crystal data for compound 3f. C10H9Cl2NOS, monoclinic,
space group P21/c, a = 8.9954(18) Å, b = 12.302(3) Å,
c = 10.472(2) Å, V = 1101.7(4) Å3, β = 108.07(3), Z = 4,
Dc = 1.580 g/cm3, μ = 0.748 mmꢀ1, F(000) = 536.
Independent reflections were obtained in the range of
3.10 < θ < 24.97°, 7979. The final least-square cycle gave
R1 = 0.0384, ωR2 = 0.0919 for 1900 reflections with
I > 2σ(I). The maximum and minimum differences of peak
and hole are 0.930 and ꢀ0.606 e/Åꢀ3, respectively.
Crystallographic data have been deposited at the Cambridge
Crystallographic Data Centre as supplementary publication
number CCDC1856303. These data can be obtained free of
charge from The Cambridge Crystallographic Data via
329.0915 found 329.0990.
2-Phenylethyl-2-methyl-N-[(p-methylphenyl)sulfonyl]-1,3–
benzothiazoline-3-formamide (3c).
White solid. Yield
56%. m.p. 143–145°C. IR (KBr, cmꢀ1) ν: 3346 (N-H),
2928 (C-H), 1694 (C=O), 1363, 1164 (O=S=O). 1H-
NMR (600 MHz, CDCl3, ppm): δ: 8.17 (s, 1H), 7.97–
6.90 (m, 9H), 3.88–3.84 (m, 1H) 3.74 (q, J = 7.8 Hz,
1H), 3.04–2.99 (m, 1H), 2.96–2.92 (m, 1H), 2.67–2.63
(m, 1H), 2.49–2.44 (m, 1H), 2.40 (s, 3H), 2.12–2.17
(m, 1H), 2.02–1.97 (m, 1H), 1.73 (s, 3H). 13C-NMR
(150 MHz, DMSO-d6, ppm): δ: 148.06, 144.63, 141.40,
136.33, 129.59, 129.59, 128.46, 128.46, 128.20,
128.20, 126.46, 125.75, 125.75, 76.10, 52.80, 41.01,
31.62, 28.46, 27.63, 21.65. HRMS (ESI): m/z calcd for
N-Phenoxyacetyl-3,4-dihydro-2H-1,4-benzothiazine (3g).
Yellow solid. Yield 37%. m.p. 125–127°C. IR (KBr,
cmꢀ1) ν: 3050 (C-H), 1665 (C=O), 1599–1397 (C=C).
1H-NMR (300 MHz, CDCl3, ppm): δ: 7.31–6.80 (m,
9H), 4.75 (s, 2H), 4.03 (s, 2H), 3.23 (t, J = 6.0 Hz, 2H).
13C-NMR (75 MHz, CDCl3, ppm): δ: 167.32, 157.81,
136.66, 129.92, 129.51, 129.51, 127.82, 127.31, 125.47,
124.91, 121.61, 114.63, 114.63, 66.30, 41.84, 28.41.
HRMS (ESI): m/z calcd for C16H15NO2S ([M + H]+)
286.0823 found 286.0898.
C20H24N2O3S2 ([M + H]+) 405.1228 found 405.1302.
N-tosyl-1-thia-4-azaspiro[4.5]decane-4-formamide (3d).
White solid. Yield 85%. m.p. 162–164°C. IR (KBr, cmꢀ1
)
ν: 3265 (N-H), 2937 (C-H), 1694 (C=O), 1363, 1164
1
(O=S=O). H-NMR (600 MHz, DMSO-d6, ppm): δ: 7.71–
7.36 (m, 4H), 7.26 (s, 1H), 3.16 (t, J = 6.0 Hz, 2H), 2.79
(t, J = 6.0 Hz, 2H), 2.37(s, 3H), 1.76–1.74 (m, 2H), 1.68–
1.64 (m, 2H), 1.51–1.45 (m, 2H), 1.41–1.37 (m, 2H),
1.27–1.24 (m, 2H). 13C-NMR (150 MHz, DMSO-d6,
ppm): δ: 141.81, 141.43, 129.27, 129.27, 125.59, 125.59,
124.18, 82.44, 50.21, 34.68, 25.03, 25.03, 24.42, 24.42,
20.89, 20.89. HRMS (ESI): m/z calcd for C16H22N2O3S2
N-Acetoxyacetyl-3,4-dihydro-2H-1,4-benzothiazine (3h).
Yellow solid. Yield 72%. m.p. 107–108°C. IR (KBr,
cmꢀ1) ν: 3020–2932 (C-H), 1739 (C=O), 1586–1368
1
(C=C). H-NMR (300 MHz, CDCl3, ppm): δ: 7.29–7.08
([M + H]+) 355.1144 found 355.1144.
(m, 4H), 4.73 (s, 2H), 3.99 (s, 2H), 3.24 (t, J = 6.0 Hz,
2H), 2.14 (s, 2H). 13C-NMR (75 MHz, CDCl3, ppm): δ:
170.62, 166.42, 136.17, 129.95, 127.81, 127.33, 125.54,
124.84, 61.88, 47.72, 28.17, 20.56. HRMS (ESI): m/z
calcd for C12H13NO3S ([M + H]+) 274.0616 found
274.0513.
N-[(p-Methylphenyl)sulfonyl]-2,3-dihydro-4H-1,4-benzothiazine-
4-formamide (3e). White solid. Yield 62%. m.p. 162–164°C.
IR (KBr, cmꢀ1) ν: 3236 (N-H), 3066 (C-H), 1693 (C=O),
1334, 1159 (O=S=O). 1H-NMR (300 MHz, CDCl3, ppm): δ:
7.96–7.18 (m, 8H), 3.86 (s, 2H), 3.11 (t, J = 6.4 Hz, 2H),
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet